Goodman Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150,859
Closed -$9.31M 48
2022
Q3
$9.31M Buy
150,859
+12,698
+9% +$801K 3.12% 7
2022
Q2
$8.54M Buy
138,161
+4,886
+4% +$303K 2.83% 16
2022
Q1
$7.92M Buy
133,275
+3,449
+3% +$220K 2.25% 28
2021
Q4
$9.43M Buy
129,826
+4,241
+3% +$292K 2.47% 20
2021
Q3
$8.77M Buy
125,585
+4,698
+4% +$330K 2.4% 16
2021
Q2
$8.32M Buy
120,887
+10,261
+9% +$685K 2.55% 21
2021
Q1
$7.15M Buy
110,626
+9,635
+10% +$621K 2.29% 24
2020
Q4
$5.88M Buy
100,991
+6,122
+6% +$369K 2.05% 26
2020
Q3
$6M Buy
94,869
+1,474
+2% +$102K 2.79% 16
2020
Q2
$7.19M Sell
93,395
-290
-0.3% -$22.2K 3.59% 11
2020
Q1
$7M Sell
93,685
-582
-0.6% -$40.2K 4.28% 4
2019
Q4
$6.13M Buy
94,267
+1,012
+1% +$65.9K 2.68% 23
2019
Q3
$5.91M Buy
93,255
+1,484
+2% +$97K 2.96% 19
2019
Q2
$6.2M Buy
91,771
+3,216
+4% +$212K 3.11% 19
2019
Q1
$5.76M Buy
88,555
+2,370
+3% +$158K 2.93% 21
2018
Q4
$5.39M Buy
86,185
+614
+0.7% +$42.9K 2.92% 21
2018
Q3
$6.61M Buy
85,571
+638
+0.8% +$48.2K 3.21% 16
2018
Q2
$6.02M Buy
84,933
+5,658
+7% +$400K 2.71% 23
2018
Q1
$5.98M Buy
+79,275
New +$6.3M 2.81% 17

Other funds holding GILD

Goodman Financial's GILD Position: Q4 2022 in Review

Goodman Financial sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 150,859 shares — an estimated $9.31M sold.

Goodman Financial first reported a position in GILD in Q1 2018 and held it in 19 quarters. The position peaked at $9.43M in Q4 2021. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Goodman Financial reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Goodman Financial sold 150,859 Gilead Sciences shares in Q4 2022, an estimated $9.31M.
  • Goodman Financial first reported a position in Gilead Sciences in Q1 2018 and held it in 19 quarters.
  • Goodman Financial's Gilead Sciences position peaked at $9.43M in Q4 2021.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Goodman Financial's 13F filing for Q4 2022, filed 9 Feb 2023.